|
 | Up a level |
Mishra, S and Cosentino, C and Tamta, AK and Khan, D and Srinivasan, S and Ravi, V and Abbotto, E and Arathi, BP and Kumar, S and Jain, A and Ramaian, AS and Kizkekra, SM and Rajagopal, R and Rao, S and Krishna, S and Asirvatham-Jeyaraj, N and Haggerty, ER and Silberman, DM and Kurland, IJ and Veeranna, RP and Jayavelu, T and Bruzzone, S and Mostoslavsky, R and Sundaresan, NR (2022) Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling. In: Nature Communications, 13 (1).
Dhandapany, PS and Kang, S and Kashyap, DK and Rajagopal, R and Sundaresan, NR and Singh, R and Thangaraj, K and Jayaprakash, S and Manjunath, CN and Shenthar, J and Lebeche, D (2021) Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin. In: Science Advances, 7 (2).
Khan, D and Ara, T and Ravi, V and Rajagopal, R and Tandon, H and Parvathy, J and Gonzalez, EA and Asirvatham-Jeyaraj, N and Krishna, S and Mishra, S and Raghu, S and Bhati, AS and Tamta, AK and Dasgupta, S and Kolthur-Seetharam, U and Etchegaray, J-P and Mostoslavsky, R and Rao, PSM and Srinivasan, N and Sundaresan, NR (2021) SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ. In: Cell Reports, 35 (9).
